Israeli Company Creates Successful Blood Test for Lung Cancer

Israeli Company Creates Successful Blood Test for Lung Cancer

Credit:(Photo: flickr/pulmonary_pathology)

A new Israeli test for lung cancer allows doctors to catch the disease while patients still have a good chance of recovery.

The Israeli company Savicell has developed a successful blood test for lung cancer, allowing the disease to be detected and treated in its earliest stages, thus boosting the chances of recovery.

Dr. Shafrira Shai — the development and production manager of Savicell — was quoted by the Hebrew news outlet Mako as saying, “This process in fact identifies the energetic profile of the cells created as a result of their specific reactions. This gives us exact information on the condition of the person, if he’s in pre-cancerous condition, the beginning stages of cancer, or other possibilities.”

Eyal Davidovitch — the company’s vice president of operations — emphasized the importance of the new test.

“Statistics indicate that if you discover lung cancer in an early stage, the chances of recovery wander on average between 50-80 percent,” he said. “If you identify it at a late stage, we’re talking about four percent — it’s unbelievable. Lung cancer is the number one killer.”

Tags: Israeli Innovation

More From Fellowship Blog

Fellowship Blog

Changing — and Saving — Lives with The Fellowship

A Fellowship staffer shares impressions of her recent trip to deliver aid to needy people in remote areas of Ukraine…a trip that changed her life.

Fellowship Blog

From Survivor to the Sports Pages

Noah Klieger survived Auschwitz and other Nazi camps to go on to cover Nazi war crimes trials and Israeli athletics as a journalist.

Fellowship Blog

Faces of The Fellowship: Dmitry

Dmitry is no stranger to hard work — he’s worked for 37 years since he was just 14.

Subscribe to our Newsletter

Stay informed about issues affecting Israel, the Jewish people, Jewish-Christian relations, receive daily devotionals, and more.